| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Veterinary Pathology, School of Veterinary Medicine, University of California, Davis, California 95616, U.S.A.
A panel of six neutralizing murine monoclonal antibodies (MAbs) to equine arteritis virus (EAV) was produced. The MAbs were characterized by Western immunoblotting assay and competitive ELISA. The six MAbs identify a single neutralization site on a 29K envelope glycoprotein. Deglycosylation of viral proteins prior to immunoblotting showed that the 29K protein is the glycosylated form of a 20K protein. Equine anti-EAV serum also strongly bound the 29K glycoprotein, as well as an unglycosylated protein of 17K. The equine antisera to EAV blocked the binding of a selected MAb to EAV, whereas normal equine serum did not. Two neutralization-resistant escape mutant (EM) variants of the EAV prototype were produced using MAb 6D10. The phenotypic properties of the EM viruses were characterized by neutralization and immunoblotting assays with two MAbs (6D10 and 5G11). The two MAbs failed to neutralize either EM virus, and they did not react in an immunoblot assay with any proteins of the EM viruses. In contrast, binding of the equine antiserum to viral proteins was equivalent with prototype and EM virus strains. These data clearly indicate that a 29K envelope glycoprotein expresses at least one neutralization determinant of EAV.
Received 15 March 1993;
accepted 9 July 1993.
This article has been cited by other articles:
|
|
 |
|
  Y. Y. Go, S. J. Wong, A. J. Branscum, V. L. Demarest, K. M. Shuck, M. L. Vickers, J. Zhang, W. H. McCollum, P. J. Timoney, and U. B. R. Balasuriya Development of a Fluorescent-Microsphere Immunoassay for Detection of Antibodies Specific to Equine Arteritis Virus and Comparison with the Virus Neutralization Test Clin. Vaccine Immunol., January 1, 2008; 15(1): 76 - 87. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. B. R. Balasuriya, E. J. Snijder, H. W. Heidner, J. Zhang, J. C. Zevenhoven-Dobbe, J. D. Boone, W. H. McCollum, P. J. Timoney, and N. J. MacLachlan Development and characterization of an infectious cDNA clone of the virulent Bucyrus strain of Equine arteritis virus J. Gen. Virol., March 1, 2007; 88(3): 918 - 924. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. B. R. Balasuriya, J. F. Hedges, V. L. Smalley, A. Navarrette, W. H. McCollum, P. J. Timoney, E. J. Snijder, and N. J. MacLachlan Genetic characterization of equine arteritis virus during persistent infection of stallions J. Gen. Virol., February 1, 2004; 85(2): 379 - 390. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Castillo-Olivares, R. Wieringa, T. Bakonyi, A. A. F. de Vries, N. J. Davis-Poynter, and P. J. M. Rottier Generation of a Candidate Live Marker Vaccine for Equine Arteritis Virus by Deletion of the Major Virus Neutralization Domain J. Virol., August 1, 2003; 77(15): 8470 - 8480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Snijder, J. C. Dobbe, and W. J. M. Spaan Heterodimerization of the Two Major Envelope Proteins Is Essential for Arterivirus Infectivity J. Virol., January 1, 2003; 77(1): 97 - 104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Castillo-Olivares, A. A. F. de Vries, M. J. B. Raamsman, P. J. M. Rottier, K. Lakhani, D. Westcott, J. P. Tearle, J. L. N. Wood, J. A. Mumford, D. Hannant, et al. Evaluation of a prototype sub-unit vaccine against equine arteritis virus comprising the entire ectodomain of the virus large envelope glycoprotein (GL): induction of virus-neutralizing antibody and assessment of protection in ponies J. Gen. Virol., October 1, 2001; 82(10): 2425 - 2435. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. B. R. Balasuriya, H. W. Heidner, J. F. Hedges, J. C. Williams, N. L. Davis, R. E. Johnston, and N. J. MacLachlan Expression of the Two Major Envelope Proteins of Equine Arteritis Virus as a Heterodimer Is Necessary for Induction of Neutralizing Antibodies in Mice Immunized with Recombinant Venezuelan Equine Encephalitis Virus Replicon Particles J. Virol., November 15, 2000; 74(22): 10623 - 10630. [Abstract] [Full Text]
|
|
|
|
 |
|
 E. Weiland, S. Bolz, F. Weiland, W. Herbst, M. J. B. Raamsman, P. J. M. Rottier, and A. A. F. De Vries Monoclonal Antibodies Directed against Conserved Epitopes on the Nucleocapsid Protein and the Major Envelope Glycoprotein of Equine Arteritis Virus J. Clin. Microbiol., June 1, 2000; 38(6): 2065 - 2075. [Abstract] [Full Text]
|
|
|
|
|
|
J. F. Hedges, U. B. R. Balasuriya, P. J. Timoney, W. H. McCollum, and N. J. MacLachlan Genetic Divergence with Emergence of Novel Phenotypic Variants of Equine Arteritis Virus during Persistent Infection of Stallions J. Virol., May 1, 1999; 73(5): 3672 - 3681. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
